The Myeloproliferative Disorders an Historical Appraisal and Personal Experiences

References

• Dameshek W. Some speculations on the myeloproliferative syndromes. Blood 1951; 6: 372–375
   PubMed Web of Science ®Google Scholar
• Di Guglielmo G. L'eritremie. Hematologica 1928; 301–347
   Google Scholar
• Di Guglielmo G. Les maladies erythrémiques. Revue d'Hématol. 1946; 1: 355–398
   Google Scholar
• Schwartz S. O., Critchlow J. Erythremic myelosis (Di Guglielmo's disease). Blood 1925; VIII: 765–793
   Google Scholar
• Martin W. J., Bard E. D. Erythroleukemia with special emphasis on the acute or incomplete variety. Report of two cases. Blood 1954; 9: 321–32
   PubMed Web of Science ®Google Scholar
• Dameshek W., Baldini M. The Di Guglielmo syndrome. Editorial. Blood 1958; 13: 192–195
   PubMed Web of Science ®Google Scholar
• Dameshek W. The Di Guglielmo syndrome revisited. Blood 1969; 34: 567–572
   PubMed Web of Science ®Google Scholar
• Sultan C., Joffroy M. Y. Etude des dysmyélopoièsis acquises idiopathiques en culture. de lle in vitro. 1973; 13: 431–436
   Google Scholar
• Sultan C. Dysmyelopoetic syndromes. In: Gralnick HR. Moderator; classification of acute leukemia. Ann. Intern. Med. 1977; 87: 740–753
   PubMedGoogle Scholar
• Sultan C., Imbert M., Sigux F. Anémie réfractaire et syndromes myélodysplastiques. Ann Méd Interne 1981; 132: 159–163
   PubMedGoogle Scholar
• Sondergaard-Petersen H. The Di Guglielmo syndrome: a study of 17 cases. I. Clinical and haematological manifestations. Acta. Med. Scand. 1975; 198: 165–174
   PubMedGoogle Scholar
• Sondergaard-Petersen H. The Di Guglielmo syndrome: a study of 17 cases. II. Periodic-Acid-Schiff staining of erythrob-lasts. Acta. Med. Scand. 1975; 198: 175–182
   PubMed Web of Science ®Google Scholar
• Roggli V., Salem A. Erythroleukemia. A study of 15 cases and literature review. Cancer 1982; 49: 101–108
   PubMed Web of Science ®Google Scholar
• Michiels J. J. Erythroleukemia and myelodysplastic syndromes: An historical appraisal and a personal view. Leukemia and Lymphoma 1993; 9: 27–34
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposal for the classification of the acute leukemias. Brit. J. Haematol. 1976; 33: 451–459
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposed revised criteria for the classification of acute myeloid leukemia. Ann. Int. Med. 1985; 103: 626–629
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposal for the classification of the myelodysplastic syndromes. Brit. J. Haematol. 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Catovsky D., Galton D. A. G. Clinical and laboratory features of de novo acute myeloid leukemia with trilineage myelodysplasia. Brit. J. Haemat. 1987; 445–450
   PubMed Web of Science ®Google Scholar
• Brito-Babapulle F., Catovsky D., Galton D. A. G. Myelodysplastic relapse of de novo myeloid leukemia with trilineage myelodysplasia: a previously unrecognized correlation. Brit. J. Haemat. 1988; 68: 41–415
   PubMed Web of Science ®Google Scholar
• Cuneo A., Van Orshoven A., Nuchaux J. L., Boogaerts M., Louwagie A., Dogen C. H., Dal Cin P., Fagiolo F., Carboldi G., Van den Berghe H. Morphologic, immunologic and cytogenetic studies for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types. Brit. J. Haemat. 1990; 75: 346–354
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Brunning R. D. The revised French-American-British classification of acute myeloid leukemia: is new better?. Ann. Int. Med. 1985; 103: 614–616
   PubMed Web of Science ®Google Scholar
• Osler W. Chronic cyanosis with polycythemia and enlarged spleen: a new clinical entity. Amer. J. Med. Sci. 1903; CXXVI: 187–201
   Google Scholar
• Osler W. A clinical lecture on erythraemia. Polycythemia with cyanosis, maladie de Vaquez. Lancet 1908; 1: 143–146
   Google Scholar
• Lucas W. S. Erythremia or polycythemia with chronic cyanosis and splenomegaly. Arch. Int. Med. 1912; X: 597–603
   Google Scholar
• Minot G. R., Buckman T. E. Erythremia (Polycythemia Rubra Vera). Am. J. Med. Sci. 1923; 166: 469–489
   Google Scholar
• Harrop G. A. Polycythemia. Medicine 1928; 7: 291–344
   Google Scholar
• Rosenthal M., Bassen F. A. Course of polycythemia. Arch. Int. Med. 1938; 62: 903–917
   Google Scholar
• Wassermann L. R. Polycythemia vera, its course and treatment: Relation to myeloid metaplasia and leukemia. Bull N.Y. Acad. Med. Sci. 1954; 30: 343–375
   PubMed Web of Science ®Google Scholar
• Wassermann L. R., Bassen F. A. Polycythemia. J. Mount Sinai Hosp. 1959; XXVI: 1–49
   Google Scholar
• Gilbert H. S. The spectrum of myeloproliferative disorders. Med. Clin. North Amer. 1973; 57(2)355
   PubMed Web of Science ®Google Scholar
• Laszlo J. Myeloproliferative Disorders (MPD): Myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia. Sem. Hematol. 1975; 12: 409–432
   PubMed Web of Science ®Google Scholar
• Glaser R. M., Walker R. I. Transitions among the myeloproliferative disorders. Ann. Int. Med. 1969; 71: 285–307
   PubMed Web of Science ®Google Scholar
• Ward H. P., Black M. H. The natural history of agno-genic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 1975; 50: 357–419
   Google Scholar
• Nowell P. C., Hungerford D. A. A minute chromosome in human granulocytic leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Spiers A. S. D., Kiew A., Baikie A. S. Neutrophile alkaline phosphatase score in chronic granulocytic leukaemia. J. Clin. Pathol. 1975; 28: 517–523
   PubMed Web of Science ®Google Scholar
• Breton-Gorius J., Reyes F., Duhamel G., Naiman A., Gorin H. C. Megakaryoblastic acute leukemia: identification by the ultrastructural demonstration of platelet peroxidase. Blood 1978; 51: 45–60
   PubMed Web of Science ®Google Scholar
• Griffin J. D., Todd R. F., Ritz J., et al. Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood 1983; 61: 85–91
   PubMed Web of Science ®Google Scholar
• San Miguel J. F., Tavares de Castro J., Matutes E., et al. Characterisation of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. Br. J. Haematol. 1985; 59: 297–309
   PubMed Web of Science ®Google Scholar
• Clough V., Geary C. G., Hashini K., Davson J., Knowlson T. Myelofibrosis in chronic granulocytic leukaemia. Br. J. Haematol. 1979; 42: 515–526
   PubMed Web of Science ®Google Scholar
• Georgiï A., Vykoupil K.-F., Buhr Th., Choritz H., Döhler U., Katoutsi V., Werner M. Chronic myeloproliferative disorders in bone marrow biopsies. Path. Res. Pract. 1990; 186: 3–27
   PubMed Web of Science ®Google Scholar
• Maniatis A. K., Arnsel S., Mitus W. J., Coleman N. Chromosome pattern of bone marrow fibroblasts in patients with chronic granulocytic leukemia. Nature 1969; 222: 1278
   PubMed Web of Science ®Google Scholar
• Greenberg B. R., Wilson F. D., Woo L., Jenks H. M. Cytogenetics of fibroblast colonies in Ph1-positive chronic myelogenous leukemia. Blood 1978; 5: 1039–1044
   Google Scholar
• Hagemeijer A. Chromosome abnormalities in CML. Baillières Clin. Haematol. 1987; 1: 963–981
   PubMedGoogle Scholar
• Groffen J., Heisterkamp H. The BCR/ABL hybrid gene. Baillières Clin. Haematol., 1: 983–999
   PubMedGoogle Scholar
• Bartram C. R. BCR-arrangement without juxtaposition of CABL in chronic myelocytic leukemia. J. Exp. Med. 1985; 162: 2175–2179
   PubMed Web of Science ®Google Scholar
• Ganesan T. S., Rassool F., Guo A. P., Thing K. H., Dowding C., Hibbin J. A., Young B. D., White H., Kumaran T. D., Galton D. A. G., Goldman J. M. Rearrangement of the BCR gene in Philadelphia chromosome negative chronic myeloid leukemia. Blood 1986; 68: 957–960
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Gartler S. M., Yoshida A. Clonal origin of chronic myelocytic leukemia in man. Proc. Natl. Acad. Sci. USA 1967; 58: 1468
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Jacobson R. J., Papayannopoulou T. Chronic myelocytic leukemia: Clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 1977; 63: 125
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Denman A. M., Jacobson R. J., Lowenthal M. N. Chronic myelocytic leukemia: Origin of some lymphocytes from leukemic stem cells. J. Clin. Invest. 1978; 62: 815
   PubMed Web of Science ®Google Scholar
• Adamson J. W., Fialkow P. J., Murphy S., Prchal J. F., Steinmann L. Polycythemia vera: Stem-cell and probable clonal origin of the disease. N. Engl. J. Med. 1976; 295: 913
   PubMed Web of Science ®Google Scholar
• Fialkow P. J., Faquet G. B., Jacobson R. J., Vaidya K., Murph S. Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell. Blood 1981; 58: 916–919
   PubMed Web of Science ®Google Scholar
• Van Slijck E. J., Weiss L., Dully M. Chromosomal evidence for the secondary role of fibroblastic proliferation in acute myelofibrosis. Blood 1970; 36: 729–735
   PubMedGoogle Scholar
• Plas van der D. C., Grosveld G., Hagemeijer A. Review of clinical, cytogenetic and molecular aspects of Ph-negative CML. Cancer Genet. Cytogenet. 1991; 52: 143–146
   PubMed Web of Science ®Google Scholar
• Franzen S. The bone marrow punctate in polycythemia vera before and after treatment with P32. Acta Med. Scand. 1953; 145: 311–314
   PubMed Web of Science ®Google Scholar
• Franzen S., Strenger G., Zajicek J. Microplanimetric studies on megakaryocytes in chronic granulocytic leukaemia and polycythaemia vera. Acta Haematol. 1961; 26: 182–193
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Abels J., Steketee J., Van Vliet H. H. D., Vuzevski V. D. Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann. Intern. Med. 1985; 102: 466–471
   PubMed Web of Science ®Google Scholar
• Kutti J., Ridell B., Weinfeld A., et al. The relation of thrombokinetics to bone marrow megakaryocytes and to size of the spleen in polycythemia vera. Scand. J. Haematol. 1973; 10: 88–95
   PubMedGoogle Scholar
• Lundin P. M., Ridell B., Weinfeld A. The significance of bone marrow morphology for the diagnosis of polycythemia vera. Scand. J. Haematol. 1972; 9: 271–282
   PubMedGoogle Scholar
• Reiffers J., Dackary D., David B., et al. Megakaryoblastic transformation of primary thrombocythaemia. Acta Haematol. 1985; 73: 228–231
   PubMed Web of Science ®Google Scholar
• Verhest A., Monsieur R. Philadelphia chromosome-positive thrombocythemia with leukemic transformation. N. Engl. J. Med. 1983; 308: 1603
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Prins M. E., Hagemeijer A., Brederoo P., Van der Meulen J., Van Vliet H. H. D.M., Abels J. Philadelphia chromosome-positive essential thrombocythemia and megakaryoblast leukemia. Amer. J. Clin. Pathol. 1987; 88: 645–652
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Ten Kate F. W. J. Erythromelalgia in thrombocythemia of various myeloproliferative disorders. Am. J. Hematol. 1992; 39: 131–136
   PubMed Web of Science ®Google Scholar
• Burkhardt R., Bartl R., Jäger K., Frisch B., Kettner G., Mahl G., Sund M. Chronic myeloproliferative disorders (CMPD). Path. Res. Pract. 1984; 179: 131–186
   PubMed Web of Science ®Google Scholar
• Greenberg B. R., Wilson F. D., Woo L., Jenks H. M. Cytogenetics of fibroblasts colonies in Ph1 translocation in a patient with primary thrombocythemia. Br. J. Haematol. 1981; 47: 571–575
   PubMed Web of Science ®Google Scholar
• Berlin M. I. Diagnosis and classification of the polycythemias. Sem. Hematol. 1975; 12: 339–351
   PubMed Web of Science ®Google Scholar
• Ellis J. T., Silver R. T., Coleman M., Geller S. A. The bone marrow in polycythemia vera. Sem. Hematol. 1975; 12: 433–444
   PubMed Web of Science ®Google Scholar
• Weinreb M. J., Chi-Fang S. H. I.H. Spurious polycythemia. Sem. Hematol. 1975; 12: 397–407
   PubMed Web of Science ®Google Scholar
• Pearson T. C., Wetherley-Mein G. The course and complications of idiopathic erythrocytosis. Clin. Lab. Haematol. 1979; 1: 189–196
   PubMedGoogle Scholar
• Najean Y., Triebel F., Dresch C. Pure erythrocytosis: Reappraisal of astudy of 51 cases. Am. J. Hematol. 1981; 10: 129–136
   PubMed Web of Science ®Google Scholar
• Westwood N., Pearson T. C. Studies of haematopoietic progenitor cells using clonogenic culture techniques in chronic myeloproliferative didorders. Leukeman and Lymphoma 1995
   Google Scholar
• Minot G. R., Buckman T. H. E. Erythremia (polycythemia rubra vera). Amer. J. Med. Sci. 1923; 166: 469–489
   Google Scholar
• Epstein E., Goedel A. Hämorrhagische Thrombocythämie bei vasculärer Schrumpfmilz. Virch. Arch. 1934; 293: 233–247
   Google Scholar
• Brugsch H. Persistierende Thrombocythämie und Leukämie nach Milzentfernung. Folia. Haemat. 1933; 49: 454–465
   Google Scholar
• Rowlands R. A., Vairey J. M. Primary thrombocythaemia. Lancet 1938; 1217–1222
   Google Scholar
• Uotila U. On hemorrhagic thrombocythemia. Acta Med. Scand. 1938; XCV: 136–150
   Google Scholar
• Reid J. Haemorrhagic Thrombocythaemia. Lancet II. 1940; 584–587
   Google Scholar
• Mortensen O. Thrombocythaemia Haemorrhagica. Acta Med. Scand. 1948; CXXIX: 547–559
   Google Scholar
• Hardisty R. M., Wolff H. N. Haemorrhagic thrombocythaemia. Brit. J. Haematol. 1955; 1: 390–405
   PubMed Web of Science ®Google Scholar
• Woodrow J. C., Cope S. Haemorrhagic thrombocythaemia treated With radioactive phosphorus. Brit. Med. J. 1955; 3: 1069
   Google Scholar
• Binswanger D., Schaub F, Zur W. Hämorrhagischen Diathese bei extremer Vermehrung der Thrombocyten (Thrombocythaemia haemorrhagica). Acta Haemat. 1955; 14: 382–386
   Google Scholar
• Koller F., Boumameaux Y. Hämorrhagische Diathese nach Splenektomie, Thrombocythaemia Haemorrhagica. Bull. Schweiz. Akad. D. Med. Wiss. 1956; 12: 248–260
   PubMedGoogle Scholar
• Spaet Th. H., Lesnieks I., Gagnor E., Goldstein M. L. Defective platelets in essential thrombocythaemia. Arch. Int. Med. 1969; 124: 135–141
   PubMed Web of Science ®Google Scholar
• Gunz F. W. Hemorrhagic Thrombocythemia. A critical review. Blood 1960; 15: 706–723
   PubMed Web of Science ®Google Scholar
• Shaw S. Haemorrhagic thrombocythaemia. Brit. Med. J. 1961; I: 1437–1438
   Google Scholar
• Fountain J. A. Haemorrhagic thrombocythaemia. Brit. J. Med. 1958; 2: 126–130
   PubMed Web of Science ®Google Scholar
• Fountain J. R., Losowsky M. S. Haemorrhagic Thrombocythaemia and its treatment with radioactive phosphorus. Quart. J. Med. 1962; 122: 207–220
   Google Scholar
• Webb A. T., Meyer F. L., Louser E. R. Hemorrhagic thrombocythemia. Arch. Int. Med. 1963; 111: 280–285
   PubMed Web of Science ®Google Scholar
• Cronberg S., Nilsson I. M. Haemorrhagic thrombocythaemia due to defect platelet adhesiveness. Scand. J. Haematol. 1965; 2: 208–219
   PubMedGoogle Scholar
• Hall W. J. Hemorrhagic thrombocythemia. JAMA 1965; 92: 912–914
   Google Scholar
• Ohler W. G. A., Friederici L., Cassenholz A. Kasuistischer Beitrag zur Krankheitsbild der hämorrhagischer Thrombozythämie. Med. Welt., 19: 1034–1037
   PubMedGoogle Scholar
• Bensinger T. A., Loque G. L., Rundler R. W. Haemorrhagic thrombocythaemia: a control of postsplenectomy thrombocytosis with Melphalan. Blood 1970; 36: 61–69
   PubMed Web of Science ®Google Scholar
• McCabe W. R., Bird M. R., McLaughlin R. A. Is primary hemorrhagic thrombocythaemia a clinical myth. Ann. Int. Med. 1955; 43: 182–190
   PubMed Web of Science ®Google Scholar
• Shaw S., Oliver R. A. M. Primary haemorrhagic thrombocythaemia. Proc. Soc. Med. 1955; 768–772
   Google Scholar
• Ozer F. L., Wayne E. I., Miesch D. C., Levin W. C. Primary hemorrhagic thrombocythemia. Amer. J. Med. 1960; 807–823
   PubMed Web of Science ®Google Scholar
• Silverstein M. N. Primary hemorrhagic thrombocythaemia. Arch. Int. Med. 1968; 122: 18–22
   PubMedGoogle Scholar
• Goudsmit R. Essentile thrombocytemie, chronische myeloïde leukemie of polycythaemia vera. NTvG 1956; 100: 1236–1239
   Google Scholar
• Wasserman L. R., Vroman L., Gelin G. Hémorragies et thromboses au cours de la thrombocythémie essentielle. Sang 1958; 29: 560–572
   PubMedGoogle Scholar
• Kupfer H. G., Ebbels B. J., Miller J. N., Thoma S. W., Russi M. Essential thrombocythaemia. Ann. Int. Med. 1958; 48: 685–697
   PubMedGoogle Scholar
• Fanger H., Cella Litchman L. J., Thrombocythemia H. New. Engl. J. Med., 250: 456–462
   PubMed Web of Science ®Google Scholar
• Baikie. Thrombocythaemia and thrombocytosis in the myeloproliferative syndromes. Scott. Med. J. 1958; 3: 26–30
   PubMedGoogle Scholar
• Robertson J. H. Uracil mustard in the treatment of throm-bocythaemia. Blood 1970; 35: 288–297
   PubMed Web of Science ®Google Scholar
• Dube B., Bajpai H. S., Chawla S. C., Supra Y. N. Platelet defects in post-splenectomy thrombocythaemia. Acta Haemat. 1971; 46: 221–227
   PubMed Web of Science ®Google Scholar
• Hermann R. E. Thrombocytosis. Its occurrence and association with abnormal bleeding. Ann. Surg. 1957; 145: 238–243
   PubMed Web of Science ®Google Scholar
• Pederson B., Videback A. A case of Haemorrhagic Thrombocytosis, treated with cytotoxics. Acta Haemat. 1961; 26: 372–377
   PubMed Web of Science ®Google Scholar
• Fleischer J. Anhaltende leukämoide Reaktionen und hämorrhagische Thrombozytosen nach Miltextirpation. Primär myeloproliferatives Syndrom. Folia. Haematologica. 1962; 6: 409–423
   PubMedGoogle Scholar
• Revol L. La myelose hyperthrombocytaire. Thrombocytémie hémorrhagique. Sang 1950; 21: 409–423
   Google Scholar
• Dugois P., Amblard P., Imbert R., De Bignicourt B. Ulcères de jambes d'origine artérielle avec hyperplaquettose et gammapathie monoclonale IgG. Bull. Soc. Fr. Drm. Syph. 1966; 76: 383–386
   Google Scholar
• Van Genderen P. J. J., Michiels J. J. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia. Presse. Med. 1994; 23: 73–77
   PubMed Web of Science ®Google Scholar
• Budde U., Schaefer G, Mueller N., Egli H., Ruggeri Z. M. Zimmerman TS. Acquired Von Willebrand's disease in the myeloproliferative syndrome. Blood 1984; 64: 981–985
   PubMed Web of Science ®Google Scholar
• Budde U., Dent J. A., Berkowitz S. D., Ruggeri Z. M., Zimmerman T. S. Subunit composition of plasma Von Willebrand factor in patients with the myeloproliferative syndrome. Blood 1986; 68: 1213–1217
   PubMed Web of Science ®Google Scholar
• Budde U., Scharf R. E., Franke P., Hartmann-Budde K., Dent J., Ruggeri Z. M. Elevated platelet count as a cause of abnormal Von Willebrand factor multimer distribution in plasma. Blood 1993; 82: 1749–1757
   PubMed Web of Science ®Google Scholar
• Van Genderen P. J. J., Michiels J. J., Van der Poel-Van de Luijtgaarde Scpam, Van Vliet H HD. Acquired Von Willebrand's disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemic relationship with platelet count. Ann. Hematol. 1994; 69: 81–84
   PubMed Web of Science ®Google Scholar
• Iland H. J., Laszlo J., Peterson P., Murphy S., Brière J., Weinfeld A., Rosenthal D. S., Landaw S. A., Ellis J. T., Silverstein M. H., Wassermann L. R. Essential throm-bocythemia:Clinical and laboratory characteristics at presentation. Trans. Assoc. Am. Phys. 1983; XCVI: 165–174
   Google Scholar
• Murphy S., Iland H., Rosenthal D., Laszlo J. Essential thrombocythemia: An interim report from the Polycythemia Vera Study Group. Sem. Hematol. 1986; 23: 177–182
   PubMed Web of Science ®Google Scholar
• Nygaard K. K., Brown G. E. Essential thrombophilia. Arch. Int. Med. 1937; 59: 82–106
   Google Scholar
• Annetts D. L., Tracy G. D. Idiopathic thrombocythaemia presenting with ischaemia of the toes. Med. J. Austr. 1966; 2: 180–182
   PubMedGoogle Scholar
• Vreeken J., Van Aken W. S. Spontaneous aggregation of blood platelets as a cause of idiopathic and recurrent painful toes and fingers. Lancet 1971; ii: 1394–1397
   Google Scholar
• Preston F. E., Emmanuel I. G., Winfield D. A., Malia R G. Essential thrombocythaemia and peripheral gangrene. Brit. Med. J. 1974; 3: 548–552
   PubMed Web of Science ®Google Scholar
• Singh A. K., Wetherley Mein G. Microvascular occlusive lesions in primary thrombocythaemia. Brit. J. Haematol. 1977; 36: 553–564
   PubMed Web of Science ®Google Scholar
• Hussain S., Schwartz J. M., Friedman S. A., Chua S. Arterial thrombosis in essential thrombocythaemia. Amer. Heart J. 1978; 96: 31–36
   PubMed Web of Science ®Google Scholar
• Redding K. G. Thrombocythemia as a cause of erythermalgia. Arch. Dermatol. 1977; 113: 468–471
   PubMed Web of Science ®Google Scholar
• Vera J. C. Antiplatelet agents in the treatment of thrombotic complications of primary thrombocythaemia. CMA Journal 1979; 120: 60–61
   PubMed Web of Science ®Google Scholar
• Mitchell S. W. On a rare vaso-motor neurosis of the extremities and on the maladies with which it may be confounded. Am. J. Med. Sc. 1878; 76: 2–36
   Google Scholar
• Smith L. A., Allen E. V. Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat and pain. Am. Heart. J. 1938; 16: 175–188
   Google Scholar
• Michiels J. J., Ten Kate F. W. J., Vuzevski V. D., Abels J. Histopathology of erythromelalgia in thrombocythaemia. Histopathology 1985; 8: 669–678
   Web of Science ®Google Scholar
• Van Genderen P. J. J., Michiels J. J., Van Strik R., Lindemans J., Van Vliet H. H. D.M. Platelet consumption in thrombocythemia complicated by erythromelalgia. Reversal by aspirin. Thromb. Haemorrh. 1995; 73: 210–214
   Google Scholar
• Jabaely J, Iland H. J., Laszlo J., et al. Neurological manifestations of essential thrombocythaemia. Ann. Intern. Med. 1983; 99: 513–8
   PubMedGoogle Scholar
• Scheffer M. G., Michiels J. J., Simoons M. L., Roelandt J. R. T.C. Thrombocythemia and coronary artery disease. Am. Heart. J. 1991; 122: 573–576
   PubMed Web of Science ®Google Scholar
• Michiels J. J., Koudstaal P. J., Mulder A. H., Van Vliet H. H. D.M. Transient neurological and ocular manifestations in primary thrombocythemia. Neurology, 43: 1107–1110
   PubMed Web of Science ®Google Scholar
• Van Genderen P. J. J., Michiels J. J. Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann. Hematol. 1993; 67: 57–62
   PubMed Web of Science ®Google Scholar
• Michiels J. J. Erythromelalgia and Thrombocythemia. A disease of platelet prostagandin metabolism. Thesis, Rotterdam 1981
   Google Scholar
• Oppenheimer B. S. Vascular occlusion in polycythemia vera. Trans. Ass. Amer. Phys. 1929; 44: 338–344
   Google Scholar
• Norman I. L., Allen E. V. The vascular complications of polycythemia vera. Am. Heart. J. 1937; 13: 257–274
   Google Scholar
• Videback A. Polycythemia vera. Course and prognosis. Acta. Med. Scand. 1950; CXXXVIII: 179–197
   Google Scholar
• Burris M. B., Arrowsmith W. R. Vascular complications of polycythemia vera. Surg. Clin. North. Amer. 1953; 33: 1023–1028
   Web of Science ®Google Scholar
• Edwards E. A., Cooley M. M. Peripheral vascular symptoms as the initial manifestation of polycythemia vera. J. Am. Med. Ass. 1970; 214: 1463–1467
   PubMed Web of Science ®Google Scholar
• Barabas A. P., Offen H. D., Meinhari E. A. The arterial complications of polycythemia vera. Brit. J. Surg. 1973; 60: 183–187
   PubMed Web of Science ®Google Scholar
• Lawrence J. H. The control of polycythemia by marrow inhibition. J. Amer. Med. Ass. 1949; 141: 13–18
   PubMed Web of Science ®Google Scholar
• Stroebel C. F., Hall B. E., Pease G. L. The use of radiophosphorus therapy in primary polycythemia. J. Am. Med. Ass. 1951; 146: 1301–1307
   PubMed Web of Science ®Google Scholar
• Wassermann L. R., Bassen F. Polycythemia. J. Mount. Sinai. Hosp. 1959; XXVI: 1
   Google Scholar
• Wassermann L. R. The treatment of polycythemia vera. Sem. Hematol. 1976; 13: 57–58
   PubMed Web of Science ®Google Scholar
• Thomas D. J., du Boulat G. H., Marshall J., Pearson T. C., Ross Russell R. W., Symon L., Wetherley-Mein G., Zilka E. Cerebral blood flow in polycythemia. Lancet 1977; ii: 161–163
   Google Scholar
• Thomas D. J., du Boulay G. H., Marshall J., Pearson T. C., Ross Russell R. W., Symon L., Wetherley-Mein G., Zilka E. Effect of haematocrit on cerebral blood-flow in man. Lancet 1977; ii: 941–943
   Web of Science ®Google Scholar
• Pearson T. C., Wetherley-Mein G. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythemia. Lancet 1978; ii: 1219–1222
   Google Scholar
• Berk P. D., Wasserman L. R., Fruchtman S. M., Goldberg J. D. Treatment of polycythemia vera: a summary of clinical trials conducted by the polycythemia vera study group. Polycythemia Vera and the Myeloproliferative Disiorders. Wasserman/Berk/Berlin WP Saunders, Philadelphia 1995; 166–194
   Google Scholar
• Berk P. D., Goldberg J. D., Donovan P. B., Fruchtman S. M., Berlin N. I., Wasserman L. R. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group Protocols. Sem. Hematol. 1986; 23: 132–143
   PubMed Web of Science ®Google Scholar
• Tartaglia A. P., Goldberg J. D., Berk P. D., Wasserman L. R. Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera. Sem. Hematol. 1986; 23: 172–186
   PubMed Web of Science ®Google Scholar
• Berk P. D., Goldberg J. D., Silverstein M. N., et al. Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy. N. Eng. J. Med. 1981; 304: 441–447
   PubMed Web of Science ®Google Scholar
• Killmann S.-A., Cronkite E. P. Treatment of polycythemia vera with myleran. Am. J. Med. Sci. 1961; 124–130
   Google Scholar
• Haanen C., Mathe G., Hayat M. Treatment of polycythemia vera by radiophosphor or busulphan: a randomized trial. Br. J. Cancer 1981; 44: 75–80
   PubMed Web of Science ®Google Scholar
• Messinezy M., Pearson T. C., Prochazka A., Wetherley-Mein G. Treatment of primary proliferative polycythemia vera by venasection and low dose busulphan: retrospective study from one centre. Br. J. Haematol. 1985; 61: 657–666
   PubMed Web of Science ®Google Scholar
• Van de Petten J. E. W., Prochazka V., Pearson T. C., Singh A. K., Dickson E. R., Wetherley-Mein G. Primary thrombocythemia treated with busulphan. Br. J. Haematol. 1986; 62: 229–237
   PubMed Web of Science ®Google Scholar
• Pearson T. C. Primary thrombocythemia: Diagnosis and management. Br. J. Haematol. 1991; 78: 145–148
   PubMed Web of Science ®Google Scholar
• Silver R. T. Interferon-α2b: a new treatment for polycythemia vera. Ann. Int. Med. 1993; 119: 1091–1092
   PubMed Web of Science ®Google Scholar
• Muller E. W., de Wolf Th J. M., Egger R., Wijermans P. W., Huijgens P. C., Halie M. R., Vellenga E. Longterm treatment with interferon-α2b for severe pruritis in patients with polycythemia vera. Br. J. Haematol. 1995; 89: 313–318
   PubMed Web of Science ®Google Scholar